These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 22556322)

  • 1. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.
    Chun S; Tu JV; Wijeysundera HC; Austin PC; Wang X; Levy D; Lee DS
    Circ Heart Fail; 2012 Jul; 5(4):414-21. PubMed ID: 22556322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.
    McManus DD; Hsu G; Sung SH; Saczynski JS; Smith DH; Magid DJ; Gurwitz JH; Goldberg RJ; Go AS;
    J Am Heart Assoc; 2013 Feb; 2(1):e005694. PubMed ID: 23525446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
    Kozdağ G; Yaymacı M; Ertaş G; Celikyurt U; Sahin T; Kılıç T; Ural D
    Heart Vessels; 2012 Nov; 27(6):568-75. PubMed ID: 21909806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005.
    Teng TH; Hung J; Knuiman M; Stewart S; Arnolda L; Jacobs I; Hobbs M; Sanfilippo F; Geelhoed E; Finn J
    Int J Cardiol; 2012 Jul; 158(3):405-10. PubMed ID: 21334755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cause-specific hospital readmission in patients with heart failure.
    Babayan ZV; McNamara RL; Nagajothi N; Kasper EK; Armenian HK; Powe NR; Baughman KL; Lima JA
    Clin Cardiol; 2003 Sep; 26(9):411-8. PubMed ID: 14524597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.
    Habal MV; Liu PP; Austin PC; Ross HJ; Newton GE; Wang X; Tu JV; Lee DS
    Circ Heart Fail; 2014 Jan; 7(1):12-20. PubMed ID: 24297690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT.
    Barkoudah E; Claggett BL; Lewis EF; O'Meara E; Clausell N; Diaz R; Fleg JL; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
    J Card Fail; 2022 Sep; 28(9):1390-1397. PubMed ID: 35636727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India.
    Harikrishnan S; Sanjay G; Agarwal A; Kumar NP; Kumar KK; Bahuleyan CG; Vijayaraghavan G; Viswanathan S; Sreedharan M; Biju R; Rajalekshmi N; Nair T; Suresh K; Jeemon P
    Am Heart J; 2017 Jul; 189():193-199. PubMed ID: 28625377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke and Heart Failure: Clinical Features, Access to Care, and Outcomes.
    Pongmoragot J; Lee DS; Park TH; Fang J; Austin PC; Saposnik G; ;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1048-1056. PubMed ID: 26853141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Tay WT; Teng TK; Simon O; Ouwerkerk W; Tromp J; Doughty RN; Richards AM; Hung CL; Qin Y; Aung T; Anand I; Lam CSP;
    J Am Heart Assoc; 2021 Nov; 10(22):e021414. PubMed ID: 34666509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection-Related Hospitalization in Heart Failure With Reduced Ejection Fraction: A Prospective Observational Cohort Study.
    Drozd M; Garland E; Walker AMN; Slater TA; Koshy A; Straw S; Gierula J; Paton M; Lowry J; Sapsford R; Witte KK; Kearney MT; Cubbon RM
    Circ Heart Fail; 2020 May; 13(5):e006746. PubMed ID: 32354281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.